Safety of medicines like paracetamol, vitamin D, blood pressure medications, and anti-diabetic drugs in doubt.
The Central Drugs Standard Control Organisation (CDSCO) has reported that 53 medicines, including paracetamol, have failed to meet quality standards. Of these, 48 were classified as "Not of Standard Quality" (NSQ), while five others in the NSG Alert category by the manufacturers.
ALSO READ: ₹6.04 Crore Of Fraudulent Trading App Frozen After ED Raids In Guwahati
The drugs that failed quality test include widely used medications like paracetamol (500 mg), Glimepiride (for diabetes), Telma H (for high blood pressure), Shelcal C and D3 (calcium supplements), and Metronidazole (used for infections). Others include Fexofenadine (for allergies), Clavam 625 (for infections), and Pan D (for acidity).
Several companies such as Hetero Drugs, Alkem Laboratories, Hindustan Antibiotics Limited, Karnataka Antibiotics, and others were among those whose products were flagged.
The CDSCO also listed five additional drugs that companies claim are spurious, including Sun Pharma’s Pulmosil (for pulmonary arterial hypertension), Pantocid (for acid reflux), and Ursocol 300, as well as Glenmark’s hypertension drug Telma H and Macleods Pharma’s Defcort 6 (for joint and muscle problems).
However, these companies have denied responsibility for the flagged drugs, stating that they had not manufactured the affected batches.
This comes shortly after the CDSCO banned over 156 drug combinations in August due to health risks. The recent findings, based on routine testing by state officials, raise concerns about the safety of medicines like paracetamol, vitamin D, blood pressure medications, and anti-diabetic drugs.
The investigation continues, and authorities are working to trace the origin of these potentially harmful or counterfeit drugs to ensure public safety.
